Abstract
M.M. Addo, E.S. Rosenberg
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1084/jem.145.3.644
10.1084/jem.145.3.644
10.1146/annurev.immunol.16.1.323
10.1146/annurev.immunol.16.1.323
10.1084/jem.189.6.991
10.1084/jem.189.6.991
10.1126/science.283.5403.857
10.1126/science.283.5403.857
10.1128/jvi.71.4.3120-3128.1997
10.1128/jvi.71.4.3120-3128.1997
CD4+ T cells are required to sustain CD8+ cytotoxic T‐cell responses during chronic viral infection
10.1128/jvi.68.12.8056-8063.1994 · 1994
10.1084/jem.188.12.2205
10.1084/jem.188.12.2205
10.1097/00000441-199305000-00005
10.1097/00000441-199305000-00005
Cytomegalovirus infection following stem cell transplantation
1999
10.1128/cmr.13.1.83-121.2000
10.1128/cmr.13.1.83-121.2000
10.1093/clinids/10.supplement_3.s460
10.1093/clinids/10.supplement_3.s460
10.1128/jvi.55.2.264-273.1985
10.1128/jvi.55.2.264-273.1985
CD8‐positive T lymphocytes specific for murine cytomegalovirus immediate‐early antigens mediate protective immunity
10.1128/jvi.61.10.3102-3108.1987 · 1987
10.1128/jvi.65.7.3641-3646.1991
10.1128/jvi.65.7.3641-3646.1991
10.1016/s0167-5699(97)80017-5
10.1016/s0167-5699(97)80017-5
10.1056/nejm198207013070102
10.1056/nejm198207013070102
10.1093/clinids/6.2.156
10.1093/clinids/6.2.156
10.1182/blood.v78.5.1373.1373
10.1182/blood.v78.5.1373.1373
Recovery of HLA‐restricted cytomegalovirus‐specific T‐cell responses after allogeneic bone marrow transplant: correlation with cytomegalovirus disease and effect of ganciclovir prophylaxis
10.1182/blood.v83.7.1971.1971 · 1994
Cytomegalovirus‐specific T‐cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants
10.1182/blood.v89.10.3873 · 1997
10.1086/314879
10.1086/314879
10.1126/science.279.5359.2103
10.1126/science.279.5359.2103
10.1097/00007890-200006150-00006
10.1097/00007890-200006150-00006
10.1097/00007890-200006150-00005
10.1097/00007890-200006150-00005
10.1097/00007890-200005150-00030
10.1097/00007890-200005150-00030
10.1099/0022-1317-79-9-2099
10.1099/0022-1317-79-9-2099
10.1038/nm0898-953
10.1038/nm0898-953
10.1097/00042560-199904150-00016
10.1097/00042560-199904150-00016
10.1002/(sici)1096-9071(199606)49:23.0.co;2-7
10.1002/(sici)1096-9071(199606)49:2<124::aid-jmv9>3.0.co;2-7
10.1086/315445
10.1086/315445
10.1126/science.280.5361.248
10.1126/science.280.5361.248
Human cytomegalovirus replication and modulation of apoptosis in astrocytes
1998
10.4049/jimmunol.164.2.926
10.4049/jimmunol.164.2.926
Cytomegalovirus infection of peripheral blood mononuclear cells. Effects on interleukin‐1 and 2 production and responsiveness
10.1128/jvi.62.10.3603-3607.1988 · 1988
10.1093/infdis/153.6.1084
10.1093/infdis/153.6.1084
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains
10.1073/pnas.93.21.11327 · 1996
Human cytomegalovirus down‐regulates HLA class I expression by reducing the stability of class I H chains
10.4049/jimmunol.151.9.4455 · 1993
10.1073/pnas.93.20.10990
10.1073/pnas.93.20.10990
10.1038/384432a0
10.1038/384432a0
10.1016/s0092-8674(00)81054-5
10.1016/s0092-8674(00)81054-5
Mature dendritic cells pulsed with freeze‐thaw cell lysates define an effective in vitro vaccine designed to elicit EBV‐specific CD4+ and CD8+ T lymphocyte responses
10.1182/blood.v96.5.1857 · doi-reference
Induction of Epstein‐Barr virus‐specific cytotoxic T‐lymphocyte responses using dendritic cells pulsed with EBNA‐3A peptides or UV‐inactivated, recombinant EBNA‐3A vaccinia virus
10.1182/blood.v94.4.1372 · doi-reference
10.1023/a:1006681312249
10.1023/a:1006681312249 · doi-reference
10.1128/jvi.74.2.914-922.2000
10.1128/jvi.74.2.914-922.2000 · doi-reference
10.1089/10430340050057521
10.1089/10430340050057521 · doi-reference
Simultaneous ex vivo expansion of cytomegalovirus and Epstein‐Barr virus‐specific cytotoxic T lymphocytes using B‐lymphoblastoid cell lines expressing cytomegalovirus pp65
10.1182/blood.v94.9.3242 · doi-reference
Mig., the monokine induced by interferon‐gamma, promotes tumor necrosis in vivo
10.1182/blood.v89.8.2635 · doi-reference
10.1086/515290
10.1086/515290 · doi-reference
Epstein‐Barr virus (EBV)‐specific cytotoxic T lymphocytes for the treatment of patients with EBV‐positive relapsed Hodgkin's disease
10.1182/blood.v91.8.2925.2925_2925_2934 · doi-reference
Epstein‐Barr virus (EBV) load in bone marrow transplant recipients at risk to develop post transplant lymphoproliferative disease: prophylactic infusion of EBV‐specific cytotoxic T cells
10.1182/blood.v95.3.807.003k24_807_814 · doi-reference
Infusion of cytotoxic T cells for the prevention and treatment of Epstein‐Barr virus‐induced lymphoma in allogeneic transplant recipients
10.1182/blood.v92.5.1549.417k32_1549_1555 · doi-reference
10.1038/nm0596-551
10.1038/nm0596-551 · doi-reference
10.1056/nejm199409083311017
10.1056/nejm199409083311017 · doi-reference
10.1056/nejm199404283301703
10.1056/nejm199404283301703 · doi-reference
10.1128/jvi.71.11.8340-8346.1997
10.1128/jvi.71.11.8340-8346.1997 · doi-reference
10.1038/375685a0
10.1038/375685a0 · doi-reference
10.1002/(sici)1097-0215(19961009)68:23.0.co;2-d
10.1002/(sici)1097-0215(19961009)68:2<251::aid-ijc19>3.0.co;2-d · doi-reference
10.1097/00007890-199812270-00001
10.1097/00007890-199812270-00001 · doi-reference
10.1128/jvi.71.10.7509-7517.1997
10.1128/jvi.71.10.7509-7517.1997 · doi-reference
Suppression of c‐Myc‐induced apoptosis by the Epstein‐Barr virus gene product BHRF1
10.1128/jvi.72.10.8392-8395.1998 · doi-reference
10.1016/s1074-7613(00)80622-6
10.1016/s1074-7613(00)80622-6 · doi-reference
10.1007/978-3-642-72045-1_8
10.1007/978-3-642-72045-1_8 · doi-reference
10.1172/jci4225
10.1172/jci4225 · doi-reference
10.1038/nm0896-906
10.1038/nm0896-906 · doi-reference
A re‐evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
10.4049/jimmunol.162.3.1827 · doi-reference
10.1084/jem.187.9.1395
10.1084/jem.187.9.1395 · doi-reference
10.1084/jem.185.9.1605
10.1084/jem.185.9.1605 · doi-reference
Antigen‐driven expansion and contraction of CD8+‐activated T cells in primary EBV infection
10.4049/jimmunol.163.10.5735 · doi-reference
10.1146/annurev.immunol.15.1.405
10.1146/annurev.immunol.15.1.405 · doi-reference
10.1128/cmr.10.1.86
10.1128/cmr.10.1.86 · doi-reference
10.1182/blood.v87.6.2594.bloodjournal8762594
10.1182/blood.v87.6.2594.bloodjournal8762594 · doi-reference
10.1182/blood.v72.2.520.520
10.1182/blood.v72.2.520.520 · doi-reference
10.1111/j.1365-2559.1992.tb01007.x
10.1111/j.1365-2559.1992.tb01007.x · doi-reference
Epstein‐Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
10.1182/blood.v71.5.1234.1234 · doi-reference
10.1126/science.285.5427.546
10.1126/science.285.5427.546 · doi-reference
10.1126/science.1352912
10.1126/science.1352912 · doi-reference
10.1056/nejm199510193331603
10.1056/nejm199510193331603 · doi-reference
10.1128/jvi.72.3.1797-1804.1998
10.1128/jvi.72.3.1797-1804.1998 · doi-reference
Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host. CD4‐helper‐independent antiviral function of CD8‐positive memory T lymphocytes derived from latently infected donors
10.1128/jvi.62.3.1061-1065.1988 · doi-reference
10.1084/jem.165.3.650
10.1084/jem.165.3.650 · doi-reference